Recent Finacing
Recent Raise
Caliway is a clinical-stage Taiwan biopharmaceutical developing CBL‑514, an injectable small-molecule lipolytic that induces adipocyte apoptosis for noninvasive subcutaneous fat reduction and treatment of lipomas, cellulite, Dercum's disease.